Stock research
BIAF bioAffinity Technologies, Inc.
Healthcare • Medical - Diagnostics & Research
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized...…
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
1Y change
-92.88%
Range high
$10.51
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in BIAF?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $0.64
- Day High
- $0.64
- Day Low
- $0.59
- 52w High
- $13.50
- 52w Low
- $0.56
- Volume
- 108,644
- Avg Volume
- Beta
- -1.11
* TTM/most recent where available
Company
- Ticker
- BIAF
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
- CEO
- Maria Zannes
- Employees
- 57
- Website
- www.bioaffinitytech.com
Key Metrics
- Market Cap
- 2.84M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).